Egrifta sponsor?

What is Egrifta’s sponsor?

Egrifta (treats HIV-associated lipodystrophy) is marketed in the U.S. by AbbVie Inc., which acts as the product sponsor/license holder in regulatory filings. [1][2]

Who might be listed as the sponsor in other countries?

The “sponsor” can differ by country because marketing authorization holders and local distributors vary by jurisdiction. If you tell me the country you mean (for example, U.S., UK, EU, Canada, Australia), I can point to the specific local sponsor name used there.

How to verify the sponsor on official documents

If you’re checking for a specific sponsor name (for example, for an IRB submission, study protocol, or regulatory packet), the sponsor/license holder is typically shown on:
- the product label or prescribing information, and
- the relevant drug regulatory database entry for that country. [1][2]

Sources

1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
   
2. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205875